Lazard Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Lazard Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $353 - $508	6 Added 100.0%	12 $0
Q2 2022 Aug 09, 2022	SELL	$79.4 - $116.36 $15,959 - $23,388	-201 Reduced 97.1%	6 $0
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $1.72 Million - $2.19 Million	-19,916 Reduced 98.97%	207 $21,000
Q4 2021 Feb 09, 2022	BUY	$98.56 - $119.91 $244,133 - $297,017	2,477 Added 14.04%	20,123 $2.17 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $1.58 Million - $1.9 Million	17,236 Added 4203.9%	17,646 $1.93 Million
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $1.15 Million - $1.28 Million	-13,334 Reduced 97.02%	410 $38,000
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $987,231 - $1.31 Million	13,744 New	13,744 $1.26 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $53,517 - $77,452	-969 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $61,668 - $116,353	-2,042 Reduced 67.82%	969 $53,000
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $74,883 - $116,104	3,011 New	3,011 $89,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.